ISPOR Latin America Conference to Focus on Improving Health Outcomes Through Stakeholder Engagement

Published Sep 5, 2017
Conference to be Held 15-17 September 2017 in São Paulo, Brazil Princeton, NJ—September 5, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading professional society for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions for its upcoming 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil. The conference scientific sessions will center of the theme, “Driving Better Health Outcomes Through Stakeholder Engagement.” The ISPOR Latin America Conference is expected to draw almost 1000 health care stakeholders including policy makers, payers, thought leaders, researchers, academicians, decision makers, and patient representatives. Scientific sessions include: Plenary #1: Latin American Health Systems Reform: Opportunities and Challenges This multistakeholder session will focus on the current status, related challenges, and future opportunities to build more sustainable and equitable health systems in Latin America. Plenary speakers include:
  • Moderator: Eduardo González-Pier, PhD, Distinguished Visiting Fellow, Center for Global Development, Washington, DC, USA
  • Speaker: Rubén Torres, MD, PhD, Dean, ISALUD University, Buenos Aires, Argentina
  • Speaker: Mauricio Vargas Fuentes, MD, MSc, Director, Public Health School, Universidad de Costa Rica and Secretariat, Latin America Alliance for Global Health, ALASAG, San Pedro, San Jose, Costa Rica
  • Speaker: Jesús Ancer Rodriguez, MD, Secretary, General Health Council, Mexico City, Mexico
  • Speaker: Jairnilson Silva Paim; Professor, Health Policy and Planning, Health Situation Analysis and Urban Violence and Health, Instituto de Saúde Coletiva, Federal University of Bahia, Bahia, Brazil
  • Speaker: Tomás Pippo Briant, MSc, Coordinator, Medicine, Technology, and Health Research Unit, Pan America Health Organization (PAHO)/Americas office of WHO in Brazil, Brasilia, Brazil
Plenary #2: The Voice of the Patient: Hearing Their Perspective and Incorporating in the Decision-Making Process This session will explore the challenges faced and opportunities available to more effectively bring the patient perspective into health care decision making. Plenary speakers include:
  • Moderator: Federico Augustovski, MD, MSc, PhD, Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina
  • Speaker: Eleanor Perfetto, RPh, PhD, MS, Senior Vice President, Strategic Initiatives, National Health Council, Washington, DC, USA
  • Speaker: Migdalia Denis, MA, President, Pulmonary Hypertension Society for Latin America, Board Member of International Alliance of Patient Organizations (IAPO), Miami, FL, USA
  • Speaker: Aline Silveira Silva, MS, Technologist at Executive Secretariat, National Committee for Health Technology Incorporation–CONITEC, Brasilia, Brazil
In addition to the plenary sessions, the ISPOR 6th Latin America Conference will feature 14 issue panels, 10 workshops, 3 forums, 5 educational symposia, and a variety of podium and poster presentations. ISPOR is also offering its renowned Essential HEOR Education Short Course curriculum of half-day training programs on Friday, 15 September at the conference. Additional information on the conference can be found at: Conference Information | Registration | Short Course Program |Sponsors | Exhibitors | Press

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB  

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×